Achieve Life Sciences
Achieve Life Sciences

Dividends • Achieve Life Sciences

ACHV

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
9/5/2024
9/27/2024
0,12
Quarterly
5/21/2024
6/14/2024
0,12
Quarterly
4/11/2024
4/19/2024
0,39
Quarterly
2/15/2024
3/15/2024
0,12
Quarterly
1/12/2024
1/23/2024
0,38
Quarterly
11/24/2023
12/20/2023
0,11
Quarterly
10/12/2023
10/20/2023
0,37
Quarterly
8/31/2023
9/25/2023
0,11
Quarterly
7/13/2023
7/21/2023
0,36
Quarterly
5/23/2023
6/16/2023
0,11
Quarterly
4/13/2023
4/21/2023
0,35
Quarterly
2/16/2023
3/17/2023
0,11
Quarterly
1/13/2023
1/24/2023
0,34
Quarterly